Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 54 EUR -1.1% Market Closed
Market Cap: 522.7m EUR
Have any thoughts about
Pharmanutra SpA?
Write Note

Pharmanutra SpA
Investor Relations

Pharmanutra SpA develops nutraceutical products and medical devices. The company is headquartered in Pisa, Pisa. The company went IPO on 2017-07-18. The firm develops nutraceutical products and medical devices. The company focuses on studying and producing formulations that are backed up in scientific research. The company is able to cover all stages of the development of a product, from its design, formulation and registration to its marketing, distribution and training of its commercial representatives. The firm offers Gestalys DHA, a nutritional supplement; Cetilar, a massage coadiuvant, improves and brings relief to joints affected by osteoarthritis; Cetilar patch, a transdermic patch containing a concentrated formulation of cetylated fatty acids (CFA) esters; SiderAL Forte; CardioSiderAL; SiderAL Folico; SiderAL; Bonecal and Novomega, among others.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Andrea Lacorte
Chairman & President
No Bio Available
Mr. Roberto Lacorte
Vice Chairman, MD & VP
No Bio Available
Mr. Carlo Volpi
Delegate Advisor, COO & Executive Director
No Bio Available
Mr. Germano Tarantino
Scientific Director & Executive Director
No Bio Available

Contacts

Address
PISA
Pisa
Via delle Lenze n. 216/B
Contacts
+390507846500
www.pharmanutra.it